Expression of mdm-2 and p53 protein in transitional cell carcinoma
- 1 January 1995
- journal article
- Published by Springer Nature in Urological Research
- Vol. 22 (6) , 349-352
- https://doi.org/10.1007/bf00296873
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Immunohistochemical evidence of abnormal expression of MDM2 and p53 in Hodgkin's diseaseCurrent Diagnostic Pathology, 1995
- mdm2 gene alterations and mdm2 protein expression in breast carcinomasThe Journal of Pathology, 1995
- Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas.1994
- p53 gene mutations and MDM2 amplification are uncommon in primary carcinomas of the uterine cervix.1993
- Narrow spectrum of infrequent p53 mutations and absence of MDM2 amplification in Ewing tumours.1993
- p53 Mutation and MDM2 amplification in human soft tissue sarcomas.1993
- MDM2 gene amplification in metastatic osteosarcoma.1993
- The mdm-2 oncogene can overcome wild-type p53 suppression of transformed cell growth.Molecular and Cellular Biology, 1993
- p53 protein expression in non-neoplastic lesions and benign and malignant neoplasms of soft tissueHistopathology, 1993
- The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivationCell, 1992